Ibritumomab en es it fr

Ibritumomab Brand names, Ibritumomab Analogs

Ibritumomab Brand Names Mixture

  • No information avaliable

Ibritumomab Chemical_Formula

C6382H9830N1672O1979S54

Ibritumomab RX_link

http://www.rxlist.com/cgi/generic3/zevalin.htm

Ibritumomab fda sheet

Ibritumomab msds (material safety sheet)

Ibritumomab Synthesis Reference

No information avaliable

Ibritumomab Molecular Weight

143375.5

Ibritumomab Melting Point

61 oC (FAB fragment), 71 oC (whole mAb) - Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000).

Ibritumomab H2O Solubility

No information avaliable

Ibritumomab State

Liquid

Ibritumomab LogP

-0.359

Ibritumomab Dosage Forms

Solution (IV Infusion)

Ibritumomab Indication

For treatment of non-Hodgkin's lymphoma

Ibritumomab Pharmacology

Zevalin binds to the CD20 antigen, which is predominantly expressed on mature B cells and on >90% of B-cell non-Hodgkin's lympohomas. The antibody leads to selective killing of B-cells.

Ibritumomab Absorption

No information avaliable

Ibritumomab side effects and Toxicity

No information avaliable

Ibritumomab Patient Information

No information avaliable

Ibritumomab Organisms Affected

Humans and other mammals